Big Pharma Boosts Cancer Drug Price By Incredibly 1400%!

What is Big Pharma doing when it comes to cancer drugs and cures? In the United States, cancer affects 39.6% of all men and women. While doctors have made significant leaps forward as far as treatment goes, the reality is that many people unfortunately won’t be able to afford some of the top medication available. This is all thanks to Big Pharma’s greed.

Big Pharma

To see this in action, look no further than Lomustine. For more than 40 years cancer patients have been taking about it at home. It treats a variety of cancer types, including lymphomas and melanomas.

A capsule of Lomustine, according to The Wall Street Journal,  cost roughly $50 in 2012. But things changed when a company called NextSource Biotechnology bought the rights to Lomustine in 2013.

The price, since then, only of a single Lomustine capsule has risen to believe it or not $768. That’s a 1,400% MORE.

Duke University neuro-oncologist Henry Friedman stated, “this is simply price gouging. People are simply not going to be able to afford it. Or, they’re going to pay a lot of money and have financial liability.”

It’s not just cancer drugs that have seen a ridiculous price hike either; in 2017, West-Ward Pharmaceuticals raised the price of 6 medications used to treat everything from inflammation to diarrhea, bipolar disorder and heart failure.

This is what Big Pharma has done: The prices of the drugs all climbed between 75% and 430%.


What makes this all the more disturbing is the FDA’s insistence on squashing companies that aim to provide natural cancer treatments.

CNN reported last year that the FDA sent out warning letters to 14 companies. These companies in some way or another advertise their products as able to treat cancer.

At the time, the director Douglas W. Stearn, FDA Office of Enforcement, claimed that the clampdown was carried out, in part, because such products might prevent people from seeking more “appropriate” treatment.

The FDA, Following that clampdown, sent out 4 letters to companies promoting marijuana-based products claiming that they have the ability to treat cancer.

The argument was the same as before; such companies are being cruel towards cancer patients and should therefore be pinched.

No word yet on when the FDA will use that same logic to clamp down on drug companies that unfairly raise the prices of so-called “appropriate” medications.



Source: DavidWolfe

Print Friendly, PDF & Email

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *